Dr Jean-Louis Robert studied chemistry at the University of Basle (CH) and obtained his Ph.D. from there in 1976. He had a post-doctoral training at the Pharmaceutical Institute of the “Eidgenössische Technische Hochschule” (ETH) in Zurich (CH). He spent one year with a pharmaceutical company before joining the National Health Laboratory (LNS) in Luxembourg. In his current position he is head of the Unit Pharmaceutical Chemistry, an official medicines control laboratory (OMCL) at the LNS; this OMCL is member of the European Directorate for the Quality of Medicines OMCL network (Council of Europe, Strasbourg). He is a member of the Committee for Human Medicinal Products (CHMP) since 1995 (co-opted member since 2004) at the European Medicines Agency (EMA) in London and chairman of the CHMP/CVMP Quality Working Party since 1995. Within the International Conference on Harmonization (ICH), he is or was involved in following topics: Validation of Analytical Procedures (Q2) as rapporteur, Common Technical Document-Quality as rapporteur, revision of the guidelines on impurities (Q3A and Q3B) as rapporteur, Pharmaceutical Development (Q8 and Q8R1), Pharmaceutical Quality System (Q10) and he was rapporteur for the Implementation Working Group ICH Q8, Q9, Q10. Currently he is in charge of the ICH Informal Quality Discussion Group. At the European Pharmacopoeia, he is chair of the Commission and member of the group of experts 10 B (synthetic products). He serves as a pharmaceutical expert at WHO. He is a member at the national ethical committee for clinical studies (CNER) and member of the management board of the Luxembourg anti-doping agency (ALAD). He is a “membre correspondant étranger” at the French “Académie Nationale de Pharmacie”.